Inovio Pharmaceuticals Inc said on Tuesday that Thermo Fisher Scientific would manufacture the drug developer’s experimental coronavirus vaccine, as it looks to boost the supply ahead of large trials this month. The company said it plans to have 100 million doses of its vaccine, INO-4800, in 2021 through its third-party manufacturers.
